Each of these genes are highly expressed in the heart and previously described as dominant-acting CHD disease genes.13,14 Among the 24 splice-altering variants found in the control cohort, 1 variant is in a recessive CHD gene, CNTRL, encoding a centriole-appendage protein centriolin. This evidence concerns the gene CNTRL and coronary artery disorder.